life sciences

Welcome to the 'life sciences' tag page at Technorati. This page features content from the farthest reaches of the Blogosphere that authors have "tagged" with 'life sciences'.

Are you an expert about 'life sciences'? Do you want to be the Technorati authority on 'life sciences'? You can write a description that will appear right here: Join Blogcritics!

Latest blogosphere posts tagged “life sciences”

 

• 2012 Venture Outlook: Some Bright Spots and Some Gloom

  
  Xconomy — Authority: 639
  Bruce V. Bigelow It’s that outlook time of year, and Mark Heesen, president of the National Venture Capital Association (NVCA), was in San Diego earlier this week, talking about the 2012 outlook for venture capital. Today he’ll make a similar presentation to the New Jersey Technology Council. Next week,  John ...
  2 days ago

• Largest-ever Australian trade mission to visit India

  
  Thaindian News — Authority: 534
  Melbourne, Jan 27 (IANS) Premier of Australia’s Victoria state Ted Baillieu is all set to lead the largest-ever Australian trade mission to India in February.More than 100 leading Victorian companies, ministers and officials would participate in the Super Trade Mission to India, the premier said Friday at the ...
  2 days ago

• OncoGenex Stays in Prostate Cancer Fray, After J&J, Medivation

  
  Xconomy — Authority: 639
  Luke Timmerman Prostate cancer was once a backwater for innovation, but suddenly it’s become one of the most competitive battlegrounds in all of biotech. And one of the darkhorses in this race, Bothell, WA and Vancouver, BC-based OncoGenex Pharmaceuticals, is getting ready to show next week whether it has another ...
  2 days ago

• Why Biogen Idec Got Out of the Corporate VC Business

  
  Xconomy — Authority: 639
  Luke Timmerman Steve Holtzman got his first taste of corporate venture capital back in 1987, when he raised money from SR One, back when it was part of an old company known as Smith, Kline & French. The concept was unorthodox 25 years ago, yet over time, most every Big Pharma company has become an active ...
  2 days ago

• Theraclone, VLST Founders Form New Antibody Startup, V-Gene

  
  Xconomy — Authority: 639
  Luke Timmerman Two of the scientific founders of a couple of Seattle’s best-funded biotech startups have come together in a new company that aims to create a valuable antibody drug candidates while burning through the least amount of venture capital possible. The new Seattle-based company, called V-Gene, is ...
  3 days ago

• Affymax Prepares to Mount First Challenge to Amgen Anemia Drug Monopoly

  
  Xconomy — Authority: 639
  Luke Timmerman Affymax shocked the world when an FDA advisory committee recommended last month that its anemia drug was good enough to earn a spot on the U.S. market. Now the Palo Alto, CA-based company (NASDAQ: AFFY ) is making all sorts of moves behind the scenes that will determine how big a bite it will ...
  4 days ago

• International Climate Policy: The Durban Platform Opens a Window

  
  OUPblog — Authority: 525
  by Robert N. Stavins In late November and early December of last year, some 195 national delegations met in Durban, South Africa, for the 17th Conference of the Parties (COP-17 ) of the United Nations Framework Convention on Climate Change (UNFCCC) , the latest in a series of international negotiations intended ...
  5 days ago

• Vertex Vows to Fight On With Alios Drugs in High-Stakes Hepatitis C Race

  
  Xconomy — Authority: 639
  Luke Timmerman Vertex Pharmaceuticals went from king of the hill in the treatment of hepatitis C to yesterday’s news in about six wild months. But while many on Wall Street say Vertex’s big drug will soon become obsolete, Vertex and its small partner in South San Francisco have quietly put themselves in ...
  5 days ago

• Millennium, Looking to Fend Off Onyx, Eagerly Awaits FDA Word on New Velcade

  
  Xconomy — Authority: 639
  Luke Timmerman The drug that made Millennium into a biotech power is on the verge of getting a subtle but meaningful upgrade, just in time to help the company fend off a serious new competing therapy from South San Francisco-based Onyx Pharmaceuticals (NASDAQ: ONXX ). Cambridge, MA-based Millennium, the cancer ...
  1 week ago

• Clarus Ventures Looks to Steer Ship Through Less Predictable Biotech Seas

  
  Xconomy — Authority: 639
  Luke Timmerman It’s never been easy to make a buck in biotech venture capital, but there used to be more predictability and logic to it, according to Clarus Ventures’ Nick Galakatos . You’d invest a few million, or tens of millions, and push a new drug or device toward some scientific validation in a few ...
  1 week ago

• Alzheimer’s and aging: A look at the facts and future

  
  MaRS Blog - Innovation and Commercialization in Canada — Authority: 106
  As busy professionals, many of us take on extra roles. For example, we care for our aging parents in addition to juggling careers and young families, a group known collectively as the “sandwich generation.” Over the next couple of decades, the “sandwiches” are going to become increasingly thin. The ...
  1 week ago

• Frazier Looks to Build Biotechs For Sale, Lay Groundwork for First Post-Crisis Fund

  
  Xconomy — Authority: 639
  Luke Timmerman Alan Frazier has been on record for a long time saying that the traditional biotech venture model is broken , and in severe need of updating. He’s been working on a new strategy for the past seven years or so, but the approach is facing its biggest test ever as Frazier prepares to raise his first ...
  1 week ago

• Consortium Develops Virtual Mouse for Lab Testing

  
  Science Business — Authority: 117
  Simcyp Ltd. in Sheffield, U.K., a consortium of pharmaceutical and biotech companies and research universities, has created a virtual lab mouse for use in cancer and toxicological research. Simcyp is a spin-off enterprise from Sheffield University that develops modeling and simulation tools for lab testing. Lab ...
  1 week ago

• Caliper life sciences

  
  Ameimx | your education learning info — Authority: 137
  Help caliper life sciences them as best you are able, but refrain from completely taking over their first grade science project. There are ones for students with financial needs, academic achievements and specific study pursuits, as well as those for students of specific racial and ethnic backgrounds and genders. An ...
  1 week ago

• Report: Asia Closing Gap in U.S. R&D Leadership

  
  Science Business — Authority: 117
  National Science Foundation’s new report on global research and development (R&D) trends, Science and Engineering Indicators 2012 , shows in the last decade, U.S. leadership in research and development has come under severe challenge from China and other countries in Asia. The report from NSF’s ...
  1 week ago

• Compound That Repairs RNA Defects Identified

  
  Science Business — Authority: 117
  Matthew Disney (Scripps Research Institute) Researchers at Scripps Research Institute in Jupiter, Florida have identified a compound that can help repair defects in ribonucleic acid (RNA), a genetic material similar to DNA used in protein synthesis. The team’s findings appear online in the journal ACS Chemical ...
  1 week ago

• Cadence Biomedical Snags First $1M to Help Disabled People Walk

  
  Xconomy — Authority: 639
  Luke Timmerman One of the co-founders of HealthTech Capital , Don Ross, offered Brian Glaister a blunt assessment last summer when the young entrepreneur came pitching a new mechanical-assist device to help disabled people walk. Ross responded that his wife, Donna Jang, is a stroke survivor who struggles to walk ...
  1 week ago

• J&J Opens San Diego Biotech Startup Center, Says ‘No Strings Attached’

  
  Xconomy — Authority: 639
  Luke Timmerman Johnson & Johnson’s West Coast research leader, Diego Miralles, has met with a lot of biotech entrepreneurs who are curious about what J&J is doing to foster more startups at its facility in San Diego. At some point, a skeptical question usually comes up. “What’s the catch?” Miralles ...
  1 week ago

• From AI to Bioengineering

  
  Xconomy — Authority: 639
  Sebastian Thrun First of all, students should be studying what they are passionate about. Clearly, computer science will continue to spread into all aspects of human life. Within computer science, I believe machine learning and AI are perhaps the biggest study opportunity today. Biology and medicine are also ...
  1 week ago

• RaNA Raises $20.7M From Atlas, SR One, Monsanto, for RNA-Based Tech

  
  Xconomy — Authority: 639
  Arlene Weintraub Generations of high school kids have been taught that only about 3 percent of the human genome is actually useful—meaning it contains genes that code proteins—and the rest is “junk DNA.” Cambridge, MA-based RaNA Therapeutics was founded on the idea that the so-called junk is actually gold, ...
  1 week ago

Comments about life sciences